| [1] |
Schnall MD, Blume J, Bluemke DA, et al.
Diagnostic architectural and dynamic features at breast MR imaging: multicenter study[J]. RadiologyRadiology, 2006, 238(1): 42-53.
doi: 10.1148/radiol.2381042117
|
| [2] |
Warren RM, Pointon L, Thompson D, et al.
Reading protocol for dynamic contrast-enhanced MR images of the breast: sensitivity and specificity analysis[J]. RadiologyRadiology, 2005, 236(3): 779-788.
doi: 10.1148/radiol.2363040735
|
| [3] |
Onishi M, Furukawa A, Takahashi M, et al.
A wide variety of dynamic contrast-enhanced MR appearances of breast cancer: pathologic correlation study[J]. Eur J RadiolEur J Radiol, 2008, 65(2): 286-292.
doi: 10.1016/j.ejrad.2007.04.003
|
| [4] |
Reddy JS, Mishra AM, Behari S, et al.
The role of diffusion-weighted imaging in the differential diagnosis of intracranial cystic mass lesions: a report of 147 lesions[J]. Surg NeurolSurg Neurol, 2006, 66(3): 246-250.
doi: 10.1016/j.surneu.2006.03.032
|
| [5] |
Yabuuchi H, Kuroiwa T, Kusumoto C, et al.
Incidentally detected lesions on contrast-enhanced MR imaging in candidates for breastconserving therapy: correlation between MR fndings and histological diagnosis[J]. J Magn Reson ImagingJ Magn Reson Imaging, 2006, 23(4): 486-492.
doi: 10.1002/jmri.20532
|
| [6] |
Siegmann KC, Krämer B, Claussen C.
Current status and new developments in breast MRI[J]. Breast Care(Basel)Breast Care(Basel), 2011, 6(2): 87-92.
|
| [7] |
Dorrius MD, Pijnappel RM, Jansen-van der Weide MC, et al.
Determination of choline concentration in breast lesions: quantitative multivoxel proton MR spectroscopy as a promising noninvasive assessment tool to exclude benign lesions[J]. RadiologyRadiology, 2011, 259(3): 695-703.
doi: 10.1148/radiol.11101855
|
| [8] |
Kuhl CK, Mielcareck P, Klaschik S, et al.
Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions[J]. RadiologyRadiology, 1999, 211(1): 101-110.
doi: 10.1148/radiology.211.1.r99ap38101
|
| [9] |
Sherif H, Mahfouz AE, Oellinger H, et al.
Peripheral washout sign on contrast-enhanced MR images of the breast[J]. RadiologyRadiology, 1997, 205(1): 209-213.
doi: 10.1148/radiology.205.1.9314987
|
| [10] |
Kinkel K, Helbich TH, Esserman LJ, et al.
Dynamic high-spatialresolution MR imaging of suspicious breast lesions: diagnostic cri-teria and interobserver variability[J]. AJR Am J RoentgenolAJR Am J Roentgenol, 2000, 175(1): 35-43.
doi: 10.2214/ajr.175.1.1750035
|
| [11] |
Moon M, Cornfeld D, Weinreb J.
Dynamic contrast-enhanced breast MR imaging[J]. Magn Reson Imaging Clin N AmMagn Reson Imaging Clin N Am, 2009, 17(2): 351-362.
doi: 10.1016/j.mric.2009.01.010
|
| [12] |
Shafqat G, Agha A, Masror I, et al.
Dynamic contrast enhanced MRI breast for lesion detection and characterization with histopathological co relation: preliminary experience at tertiary care hospital[J]. J Pak Med AssocJ Pak Med Assoc, 2011, 61(3): 252-255.
|
| [13] |
Goto M, Ito H, Akazawa K, et al.
Diagnosis of breast tumors by contrast-enhanced MR imaging: comparison between the diagnostic performance of dynamic enhancement patterns and morphologic features[J]. J Magn Reson ImagingJ Magn Reson Imaging, 2007, 25(1): 104-112.
doi: 10.1002/jmri.20812
|
| [14] |
Jansen SA, Newstead GM, Abe H, et al.
Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade[J]. RadiologyRadiology, 2007, 245(3): 684-691.
doi: 10.1148/radiol.2453062061
|
| [15] |
Isomoto I, Koshiishi T, Okimoto T, et al.
Gradually enhancing breast cancer on dynamic MRI[J]. Nihon Igaku Hoshasen Gakkai ZasshiNihon Igaku Hoshasen Gakkai Zasshi, 2000, 60(9): 514-519.
|
| [16] |
Yabuuchi H, Matsuo Y, Okafuji T, et al.
Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images[J]. J Magn Reson ImagingJ Magn Reson Imaging, 2008, 28(5): 1157-1165.
doi: 10.1002/jmri.21570
|
| [17] |
Marini C, Iacconi C, Giannelli M, et al.
Quantitative diffusionweighted MR imaging in the differential diagnosis of breast lesion[J]. Eur RadiolEur Radiol, 2007, 17(10): 2646-2655.
doi: 10.1007/s00330-007-0621-2
|
| [18] |
Park MJ, Cha ES, Kang BJ, et al.
The role of diffusion-weighted imaging and the apparent diffusion coefficient(ADC)valuesforbreast tumors[J]. Korean J RadiolKorean J Radiol, 2007, 8(5): 390-396.
doi: 10.3348/kjr.2007.8.5.390
|
| [19] |
Paran Y, Bendel P, Margalit R, et al.
Water diffusion in the different microenvironments of breast cancer[J]. NMR BiomedNMR Biomed, 2004, 17(4): 170-180.
doi: 10.1002/nbm.882
|
| [20] |
Yoshikawa MI, Ohsumi S, Sugata S, et al.
Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer[J]. Radiat MedRadiat Med, 2008, 26(4): 222-226.
doi: 10.1007/s11604-007-0218-3
|
| [21] |
Manenti G, Di Roma M, Mancino S, et al.
Malignant renal neoplasms: correlation between ADC values and cellularity in diffusion weighted magnetic resonance imaging at 3 T[J]. Radiol MedRadiol Med, 2008, 113(2): 199-213.
doi: 10.1007/s11547-008-0246-9
|
| [22] |
Matsumoto Y, Kur da M, Matsuya R, et al.
In vitro experimental study of the relationship between the apparent diffusion coefficient and changes in cellularity and cell morphology[J]. Oncol RepOncol Rep, 2009, 22(3): 641-648.
|
| [23] |
Jenkinson MD, du Plessis DG, Smith TS, et al.
Cellularity and apparent diffusion coefficient in oligodendroglial tumours characterized by genotype[J]. J NeurooncolJ Neurooncol, 2010, 96(3): 385-392.
doi: 10.1007/s11060-009-9970-9
|
| [24] |
Englander SA, Ulu AM, Brem R, et al.
Diffusion imaging of human breast[J]. NMR BiomedNMR Biomed, 1997, 10(7): 348-352.
doi: 10.1002/(SICI)1099-1492(199710)10:7<348::AID-NBM487>3.0.CO;2-R
|
| [25] |
Kul S, Cansu A, Alhan E, et al.
Contribution of diffusion-weighted imaging to dynamic contrast-enhanced MRI in the characterization of breast tumors[J]. AJR Am J RoentgenolAJR Am J Roentgenol, 2011, 196(1): 210-217.
doi: 10.2214/AJR.10.4258
|
| [26] |
Woodhams R, Matsunaga K, Iwabuchi K, et al.
Diffusion-weighted imaging of malignant breast tumors: the usefulness of apparent diffusion coefficient(ADC)value and ADC map for the detection of malignant breast tumors and evaluation of cancer extension[J]. J Comput Assist TomogrJ Comput Assist Tomogr, 2005, 29(5): 644-649.
doi: 10.1097/01.rct.0000171913.74086.1b
|
| [27] |
Costantini M, Belli P, Rinaldi P, et al.
Diffusion-weighted imaging in breast cancer: relationship between apparent diffusion coefficient and tumour aggressiveness[J]. Clin RadiolClin Radiol, 2010, 65(12): 1005-1012.
doi: 10.1016/j.crad.2010.07.008
|
| [28] |
Yamada K, Kubota H, Kizu O, et al.
Effect of intravenous gadolinium-DTPA on diffusion-weighted images: evaluation of normal brain and infarcts[J]. StrokeStroke, 2002, 33(7): 1799-1802.
doi: 10.1161/01.STR.0000020355.29423.61
|
| [29] |
Firat AK, Sanli B, Karakas HM, et al.
The effect of intravenous gadolinium-DTPA on diffusion-weighted imaging[J]. NeuroradiologyNeuroradiology, 2006, 48(7): 465-470.
doi: 10.1007/s00234-006-0091-2
|
| [30] |
Yuen S, Yamada K, Goto M, et al.
Microperfusion-induced elevation of ADC is suppressed after contrast in breast carcinoma[J]. J Magn Reson ImagingJ Magn Reson Imaging, 2009, 29(5): 1080-1084.
doi: 10.1002/jmri.21743
|
| [31] |
Kuroki Y, Nasu K.
Advances in breast MRI: diffusion-weighted imaging of the breast[J]. Breast CancerBreast Cancer, 2008, 15(3): 212-217.
doi: 10.1007/s12282-008-0050-3
|
| [32] |
Kvistad KA, Rydland J, Vainio J, et al.
Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging[J]. RadiologyRadiology, 2000, 216(2): 545-553.
doi: 10.1148/radiology.216.2.r00au36545
|
| [33] |
Buteau-Lozano H, Velasco G, Cristofari M, et al.
Xenoestrogens modulate vascular endothelial growth factor secretion in breast cancer cells through an estrogen receptor-dependent mechanism[J]. J EndocrinolJ Endocrinol, 2008, 196(2): 399-412.
|
| [34] |
Liu Y, Tamimi RM, Collins LC, et al.
The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses'Health Study[J]. Breast Cancer Res TreatBreast Cancer Res Treat, 2011, 129(1): 175-184.
doi: 10.1007/s10549-011-1432-3
|
| [35] |
Zhuang XM, Zhang B, Zhu B, et al.
Application of T2*-weighted first-pass perfusion imaging in the diagnosis of breast tumors[J]. ChinGer J Clin OncolChinGer J Clin Oncol, 2007, 6(4): 357-360.
doi: 10.1007/s10330-007-0053-0
|
| [36] |
Ferrier MC, Sarin H, Fung SH, et al.
Validation of dynamic contrast-enhanced magnetic resonance imaging-derived vascular permeability measurements using quantitative autoradiography in the RG2 rat brain tumor model[J]. NeoplasiaNeoplasia, 2007, 9(7): 546-555.
doi: 10.1593/neo.07289
|
| [37] |
Zhu DC, Buonocore MH.
Breast tissue differentiation using arterial spin tagging[J]. Magn Reson MedMagn Reson Med, 2003, 50(5): 966-975.
doi: 10.1002/mrm.10616
|
| [38] |
Iacconi C.
Diffusion and perfusion of the breast[J]. Eur J RadiolEur J Radiol, 2010, 76(3): 386-390.
doi: 10.1016/j.ejrad.2010.03.009
|
| [39] |
Tozaki M, Fukuda Y, Fukuda K.
Multi-section magnetic susceptibility perfusion echo-planar imaging of the breast[J]. Nihon Igaku Hoshasen Gakkai ZasshiNihon Igaku Hoshasen Gakkai Zasshi, 2003, 63(5): 214-220.
|
| [40] |
Delille JP, Slanetz PJ, Yeh ED, et al.
Hormone replacement therapyin postmenopausal women: breast tissue perfusion determined with MRimaging----initialobservations[J]. RadiologyRadiology, 2005, 235(1): 36-41.
doi: 10.1148/radiol.2351040012
|
| [41] |
Makkat S, Luypaert R, Sourbron S, et al.
Quantification of perfusion and permeability in breast tumors with a deconvolution-based analysis of second-bolus T1-DCE data[J]. J Magn Reson ImagingJ Magn Reson Imaging, 2007, 25(6): 1159-1167.
doi: 10.1002/jmri.20937
|
| [42] |
Sardanelli F, Fausto A, Podo F.
MR spectroscopy of the breast[J]. Radiol MedRadiol Med, 2008, 113(1): 56-64.
doi: 10.1007/s11547-008-0228-y
|
| [43] |
Sitter B, Bathen TF, Singstad TE, et al.
Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy[J]. NMR BiomedNMR Biomed, 2010, 23(4): 424-431.
doi: 10.1002/nbm.1478
|
| [44] |
Tse GM, Cheung HS, Pang LM, et al.
Characterization of lesions of the breast with proton MR spectroscopy: comparison of carcinomas, benign lesions, and phyllodes tumors[J]. AJR Am J RoentgenolAJR Am J Roentgenol, 2003, 181(5): 1267-1272.
doi: 10.2214/ajr.181.5.1811267
|
| [45] |
Huang W, Fisher PR, Dulaimy K, et al.
Detection of breast malignancy: diagnostic MR protocol for improved specificity[J]. RadiologyRadiology, 2004, 232(2): 585-591.
doi: 10.1148/radiol.2322030547
|
| [46] |
Bartella L, Morris EA, Dershaw DD, et al.
Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study[J]. RadiologyRadiology, 2006, 239(3): 686-692.
doi: 10.1148/radiol.2393051046
|
| [47] |
Stanwell P, Mountford C.
In vivo proton MR spectroscopy of the breast[J]. RadiographicsRadiographics, 2007, 27 Suppl 1: S253-266.
|
| [48] |
Tse GM, Yeung DK, King AD, et al.
In vivo proton magnetic resonance spectroscopy of breast lesions: an update[J]. Breast Cancer Res TreatBreast Cancer Res Treat, 2007, 104(3): 249-255.
doi: 10.1007/s10549-006-9412-8
|
| [49] |
Tozaki M.
Proton MR spectroscopy of the breast[J]. Breast CancerBreast Cancer, 2008, 15(3): 218-223.
doi: 10.1007/s12282-008-0048-x
|
| [50] |
Bartella L, Huang W.
Proton MR spectroscopy of the breast[J]. Breast CancerBreast Cancer, 2007, 27 Suppl 1: S241-252.
|
| [51] |
Tozaki M, Fukuma E.
1H MR spectroscopy and diffusion-weighted imaging of the breast: are they useful tools for characterizing breast lesionsbeforebiopsy?[J]. AJRAmJRoentgenolAJRAmJRoentgenol, 2009, 193(3): 840-849.
|
| [52] |
Stanwell P, Gluch L, Clark D, et al.
Specificity of choline metabolites for in vivo diagnosis of breast cancer using 1H MRS at 1.5 T[J]. Eur RadiolEur Radiol, 2005, 15(5): 1037-1043.
doi: 10.1007/s00330-004-2475-1
|
| [53] |
Glunde K, Jie C, Bhujwalla ZM.
Molecular causes of the aberrant choline phospholipid metabolism in breast cancer[J]. Cancer ResCancer Res, 2004, 64(12): 4270-4276.
doi: 10.1158/0008-5472.CAN-03-3829
|
| [54] |
Bolan PJ, Meisamy S, Baker EH, et al.
In vivo quantification of choline compounds in the breast with 1H MR spectroscopy[J]. Magn Reson MedMagn Reson Med, 2003, 50(6): 1134-1143.
doi: 10.1002/mrm.10654
|
| [55] |
Yeung DK, Yang WT, Tse GM.
Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases[J]. RadiologyRadiology, 2002, 225(1): 190-197.
doi: 10.1148/radiol.2243011519
|
| [56] |
Seenu V, Pavan Kumar MN, Sharma U, et al.
Potential of magnetic resonance spectroscopy to detect metastasis in axillary lymph nodes in breast cancer[J]. Magn Reson ImagingMagn Reson Imaging, 2005, 23(10): 1005-1010.
doi: 10.1016/j.mri.2005.10.004
|
| [57] |
Jagannathan NR, Kumar M, Seenu V, et al.
Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer[J]. Br J CancerBr J Cancer, 2001, 84(8): 1016-1022.
doi: 10.1054/bjoc.2000.1711
|
| [58] |
Meisamy S, Bolan PJ, Baker EH, et al.
Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo(1)H MR spectroscopy——a pilot study at 4 T[J]. RadiologyRadiology, 2004, 233(2): 424-431.
doi: 10.1148/radiol.2332031285
|
| [59] |
Nelson MT, Everson LI, Garwood M, et al.
MR Spectroscopy in the diagnosis and treatment of breast cancer[J]. Semin Breast DisSemin Breast Dis, 2008, 11(2): 100-105.
doi: 10.1053/j.sembd.2008.03.004
|
| [60] |
Tozaki M, Sakamoto M, Oyama Y, et al.
Predicting pathological response to neoadjuvant chemotherapy in breast cancer with quantitative 1H MR spectroscopy using the external standard method[J]. J Magn Reson ImagingJ Magn Reson Imaging, 2010, 31(4): 895-902.
doi: 10.1002/jmri.22118
|
| [61] |
Tafreshi NK, Kumar V, Morse DL, et al.
Molecular and functional imaging of breast cancer[J]. Cancer ControlCancer Control, 2010, 17(3): 143-155.
doi: 10.1177/107327481001700302
|
| [62] |
Jacobs MA, Barker PB, Argani P, et al.
Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study[J]. J Magn Reson ImagingJ Magn Reson Imaging, 2005, 21(1): 23-28.
doi: 10.1002/jmri.20239
|
| [63] |
Hirose M, Nobusawa H, Gokan T.
MR ductography: comparison with conventional ductography as a diagnostic method in patients with nipple discharge[J]. RadiographicsRadiographics, 2007, Suppl 1: S183-196.
|
| [64] |
Rovno HD, Siegelman ES, Reynolds C, et al.
Solitary intraductal papilloma: findings at MR imaging and MR galactography[J]. AJR Am J RoentgenolAJR Am J Roentgenol, 1999, 172(1): 151-155.
doi: 10.2214/ajr.172.1.9888758
|
| [65] |
Kanemaki Y, Kurihara Y, Itoh D, et al.
MR mammary ductography using a microscopy coil for assessment of intraductal lesions[J]. AJR Am J RoentgenolAJR Am J Roentgenol, 2004, 182(5): 1340-1342.
doi: 10.2214/ajr.182.5.1821340
|
| [66] |
Bhattarai N, Kanemaki Y, Kurihara Y, et al.
Intraductal papilloma: features on MR ductography using a microscopic coil[J]. AJR Am J RoentgenolAJR Am J Roentgenol, 2006, 186(1): 44-47.
doi: 10.2214/AJR.04.1600
|